Genscript Biotech

ISIN KYG3825B1059

 | 

WKN A2ACSB

Market cap (in EUR)
3,120 m
Country
China
Sector
Healthcare
Dividend yield
0.00%
 

Overview

Description

Genscript Biotech Corp. is a holding company, which engages in the manufacture and sale of life sciences research products and services. It operates through the following segments: Bio-science Services and Products; Precision Immune-cell Therapy; and Industrial Synthetic Biology Products. The Bio-science Services and Products segment includes life sciences research services, life sciences research catalogue products, and preclinical drug development services. The Precision Immune-cell Therapy segment discovers and develops therapies for the treatment of liquid tumour through optimised CAR structures and the development of bispecific CAR-T therapies. The Industrial Synthetic Biology Products segment comprises of the construction of non-pathogenic microbial strains and industrial enzyme development and production. The company was founded by Fang Liang Zhang, Lu Quan Wang, and Ye Wang in 2002 and is headquartered in Nanjing, China.
Show more Show less
Healthcare Healthcare Services Miscellaneous Healthcare China

Financials

Key metrics

Market capitalisation, EUR 3,120 m
EPS, EUR -
P/B ratio 0.9
P/E ratio 0.9
Dividend yield 0.00%

Income statement (2025)

Revenue, EUR 851 m
Net income, EUR -472 m
Profit margin -55.53%

What ETF is Genscript Biotech in?

There are 22 ETFs which contain Genscript Biotech. All of these ETFs are listed in the table below. The ETF with the largest weighting of Genscript Biotech is the iShares MSCI Emerging Markets Islamic UCITS ETF.
ETF Weight Investment focus Fund size (in m EUR)
iShares MSCI AC Far East ex-Japan UCITS ETF 0.02%
Equity
Asia Pacific
1,694
Vanguard LifeStrategy 80% Equity UCITS ETF (EUR) Accumulating 0.00%
Equity
World
Multi-Asset Strategy
1,117
Vanguard LifeStrategy 20% Equity UCITS ETF Distributing 0.00%
Equity
World
Multi-Asset Strategy
16
iShares MSCI ACWI UCITS ETF USD (Acc) 0.00%
Equity
World
28,619
UBS Core MSCI EM UCITS ETF USD dis 0.02%
Equity
Emerging Markets
2,694
iShares MSCI EM UCITS ETF (Dist) 0.02%
Equity
Emerging Markets
9,153
Vanguard LifeStrategy 80% Equity UCITS ETF Distributing 0.00%
Equity
World
Multi-Asset Strategy
82
Vanguard LifeStrategy 40% Equity UCITS ETF Accumulating 0.00%
Equity
World
Multi-Asset Strategy
225
Vanguard LifeStrategy 60% Equity UCITS ETF Accumulating 0.00%
Equity
World
Multi-Asset Strategy
847
Vanguard ESG Global All Cap UCITS ETF (USD) Distributing 0.00%
Equity
World
Social/Environmental
551
Vanguard ESG Emerging Markets All Cap UCITS ETF (USD) Distributing 0.02%
Equity
Emerging Markets
Social/Environmental
18
iShares MSCI EM IMI Screened UCITS ETF USD (Dist) 0.01%
Equity
Emerging Markets
Social/Environmental
1,296
iShares MSCI EM ESG Enhanced CTB UCITS ETF USD (Dist) 0.04%
Equity
Emerging Markets
Social/Environmental
1,279
Vanguard FTSE All-World UCITS ETF (USD) Accumulating 0.00%
Equity
World
40,588
Vanguard FTSE Emerging Markets UCITS ETF (USD) Accumulating 0.02%
Equity
Emerging Markets
1,885
Amundi Core MSCI Emerging Markets UCITS ETF EUR Dist 0.02%
Equity
Emerging Markets
1,171
Vanguard FTSE Emerging Markets UCITS ETF (USD) Distributing 0.02%
Equity
Emerging Markets
3,171
iShares MSCI Emerging Markets Islamic UCITS ETF 0.05%
Equity
Emerging Markets
Islamic Investing
703
Vanguard LifeStrategy 40% Equity UCITS ETF Distributing 0.00%
Equity
World
Multi-Asset Strategy
42
Vanguard LifeStrategy 60% Equity UCITS ETF Distributing 0.00%
Equity
World
Multi-Asset Strategy
109
Vanguard FTSE All-World UCITS ETF (USD) Distributing 0.00%
Equity
World
22,201
Vanguard LifeStrategy 20% Equity UCITS ETF Accumulating 0.00%
Equity
World
Multi-Asset Strategy
98
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.

Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.